Related Experiment Video
Updated: Mar 1, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Restenosis of the Coronary Arteries: Past, Present, Future Directions
Julius B Elmore1, Emile Mehanna1, Sahil A Parikh1
1Department of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Mailstop Lakeside 5038, Cleveland, OH 44106, USA.
Insights
Restenosis, or vessel re-narrowing after stenting, remains a key challenge in cardiovascular interventions. Preventing this pathologic response is crucial, as new treatments emerge to combat this condition.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Biology
Background:
- Restenosis is a pathological vascular response to injury, marked by neointimal hyperplasia and vessel narrowing.
- Despite improved stent designs, restenosis persists as a leading cause of target lesion failure after percutaneous coronary intervention.
- Established restenosis presents significant treatment challenges.
Purpose of the Study:
- To highlight the ongoing significance of restenosis following percutaneous coronary intervention.
- To emphasize the importance of preventing restenosis through risk factor management and personalized strategies.
- To introduce emerging therapeutic approaches for managing restenosis.
Main Methods:
- Review of current understanding of restenosis pathophysiology.
- Analysis of the impact of stent design advancements.
- Discussion of risk factor modification and individualized treatment approaches.
- Exploration of novel therapeutic strategies.
Main Results:
- Restenosis continues to be a primary cause of treatment failure post-intervention.
- Preventive measures, including risk factor control, are critical for managing restenosis.
- Novel therapeutic avenues show promise in altering the course of restenosis.
Conclusions:
- Restenosis remains a significant clinical problem despite technological advances.
- Proactive prevention and individualized patient management are essential.
- Future research and novel therapies are anticipated to improve outcomes for restenosis.
Abstract:
Restenosis is a pathologic response to vascular injury, characterized by neointimal hyperplasia and progressive narrowing of a stented vessel segment. Although advances in stent design have led to a dramatic reduction in the incidence of restenosis, it continues to represent the most common cause of target lesion failure following percutaneous coronary intervention. Efforts to maximize restenosis prevention, through careful consideration of modifiable risk factors and an individualized approach, are critical, as restenosis, once established, can be particularly difficult to treat. Novel approaches are on the horizon that have the potential to alter the natural history of this stubborn disease.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:26Coronary Artery Disease II: Pathophysiology
01:30Atherosclerosis I: Introduction
01:30Coronary Artery Disease I: Introduction
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:26Atherosclerosis III: Management